Schonfeld Strategic Advisors »

Tempest Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Tempest Therapeutics (TPST) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Tempest Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tempest Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempest Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $45k 10k 4.40

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
Ishares Msci Brazil Etf Call Option (EWZ)
Ishares Tr U.s. Real Es Etf (IYR)
Mastercard Incorporated Cl A (MA)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Verizon Communications (VZ)
Spdr Ser Tr S&p Biotech (XBI)
Micron Technology (MU)
Johnson Ctls Intl SHS (JCI)

View all positions for Schonfeld Strategic Advisors

Top funds holding Tempest Therapeutics

Vanguard Group
Ikarian Capital
Two Sigma Investments
Citadel Advisors
Simplex Trading
Bank of America Corporation
Two Sigma Securities
Advisor Group Holdings
Virtu Financial
Tocqueville Asset Management
Schonfeld Strategic Advisors
Bank Of Montreal
MayTech Global Investments
Cutler
UBS Group

View all funds holding Tempest Therapeutics